¼¼°èÀÇ IV µå·¹½Ì ½ÃÀå
IV Dressings
»óǰÄÚµå : 1786764
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 266 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ IV µå·¹½Ì ½ÃÀåÀº 2030³â±îÁö 22¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 17¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â IV µå·¹½Ì ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 4.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 22¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Åõ¸í ºÎ¹®Àº CAGR 5.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 15¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ÝÅõ¸í ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 2.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 6,540¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ IV µå·¹½Ì ½ÃÀåÀº 2024³â¿¡´Â 4¾ï 6,540¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4¾ï 5,870¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.1%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.7%¿Í 3.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

IV µå·¹½Ì ½ÃÀå : ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¤¸Æ ³»(IV) µå·¹½ÌÀº IV Ä«Å×Å͸¦ ¾ÈÁ¤ÀûÀ¸·Î »ðÀÔÇϰí, °¨¿°À» ¿¹¹æÇϸç, »ðÀÔ ºÎÀ§¸¦ ¿ÜºÎ ¿À¿° ¹°Áú·ÎºÎÅÍ º¸È£ÇÏ´Â ÀÇ·á ÇöÀåÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼ÒÀÔ´Ï´Ù. IV µå·¹½Ì¿¡´Â Åõ¸í Çʸ§ µå·¹½Ì, ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì, Ç×±Õ µå·¹½Ì, Æû µå·¹½Ì µî ´Ù¾çÇÑ ¼ÒÀç°¡ ÀÖÀ¸¸ç, È®½ÇÇÑ Á¢Âø·Â, Åë±â¼º, ½Àµµ Á¶ÀýÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. º´¿ø ³» °¨¿°(HAI)°ú Ä«Å×ÅÍ °ü·Ã Ç÷·ù°¨¿°(CRBSI)ÀÌ ¿©ÀüÈ÷ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Áß¿äÇÑ À̽´·Î ¶°¿À¸£¸é¼­, Ç×±Õ¼º°ú Á¢Âø·ÂÀ» °­È­ÇÑ °í±Þ IV µå·¹½Ì ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ½Ã½ºÅÛÀÌ °¨¿° °ü¸®, ȯÀÚÀÇ Æí¾ÈÇÔ, µå·¹½ÌÀÇ ³»±¸¼ºÀ» Áß¿ä½ÃÇÏ´Â °¡¿îµ¥, IV µå·¹½Ì ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Ç×±Õ ±â¼ú, ½Àµµ °ü¸®, Åë±â¼º ¼ÒÀçÀÇ Çõ½ÅÀÌ Á¦Ç°ÀÇ ¹ßÀüÀ» ÃËÁøÇϰí, ÀçÅà Åõ¾à Ä¡·á ¹× Àå±â Ä«Å×ÅÍ »ç¿ë Áõ°¡´Â ½ÃÀå ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô IV µå·¹½ÌÀ» °³¼±Çϰí Àִ°¡?

ÃÖ±Ù ±â¼ú Çõ½ÅÀ¸·Î IV µå·¹½ÌÀÇ ¼º´É, ³»±¸¼º, °¨¿° ¹æÁö ±â´ÉÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â IV µå·¹½Ì¿¡ Ç×±ÕÁ¦¸¦ ÅëÇÕÇÏ´Â °ÍÀÔ´Ï´Ù. ÀºÀÌ ÇÔÀ¯µÈ µå·¹½Ì Àç·á¿Í Ŭ·Î¸£Çí½Ãµò ÄÚÆÃ µå·¹½Ì Àç·á´Â Á¤¸ÆÁÖÀÔ ºÎÀ§ ÁÖº¯ÀÇ ¹Ì»ý¹° ±ºÁý Çü¼ºÀ» °¨¼Ò½ÃÄÑ CRBSI ¹× ±âŸ Ä«Å×ÅÍ °ü·Ã °¨¿°À» ¿¹¹æÇÏ´Â µ¥ È¿°úÀûÀÓÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ç×±Õ µå·¹½Ì Àç·á´Â ¸é¿ª °áÇÌ È¯ÀÚ, Àå±â Á¤¸Æ ³» Ä¡·á¸¦ ¹Þ°í Àִ ȯÀÚ, ÁßÁõ ȯÀÚ¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ±â¼ú Çõ½ÅÀº Åë±â¼º°ú Á¶½À¼ºÀÌ ¶Ù¾î³­ µå·¹½Ì ¼ÒÀçÀÇ °³¹ßÀÔ´Ï´Ù. ÃֽŠIV µå·¹½ÌÀº ¹ÚÅ׸®¾Æ ¹× ¿ÜºÎ ¿À¿° ¹°Áú¿¡ ´ëÇÑ º¸È£ À庮À» À¯ÁöÇϸ鼭 ¼öºÐ Áõ¹ßÀ» °¡´ÉÇÏ°Ô ÇÏ´Â °íÅõ°ú¼º Çʸ§ ¼ÒÀç¿Í ÇÏÀ̵å·ÎÄÝ·ÎÀ̵å ÃþÀÌ ³»ÀåµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ƯÈ÷ ½Àµµ°¡ ³ôÀº ȯ°æÀ̳ª Ȱµ¿ÀûÀΠȯÀÚ¿¡¼­ ÇǺΠħÀ±À» ÁÙÀÌ°í ´õ ±ä Âø¿ë ½Ã°£À» ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¶ÇÇÑ, Á¡Âø ±â¼úÀÇ ¹ßÀüÀ¸·Î ¶¼¾î³¾ ¶§ ÇǺΠ¼Õ»ó ¾øÀÌ È®½ÇÇÏ°Ô Á¢ÂøµÇ´Â ÇǺΠģȭÀûÀ̰í ÀÚ±ØÀÌ ÀûÀº Á¡ÂøÁ¦°¡ °³¹ßµÇ¾ú½À´Ï´Ù. ÀÌ´Â ³ëÀΠȯÀÚ, ½Å»ý¾Æ °ü¸®, ÇǺΰ¡ ¾àÇÑ È¯ÀÚ¿¡°Ô ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ÇöÀç ÀϺΠIV µå·¹½ÌÀº ½Ç¸®ÄÜ ±â¹Ý Á¢ÂøÁ¦¸¦ ÅëÇÕÇÏ¿© ÇǺΠ¹Ú¸® ¹× ºÒÆíÇÔÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 °ß°íÇÑ Á¢ÂøÀ» ½ÇÇöÇϰí ÀÖ½À´Ï´Ù.

¼¾¼­ ÀÏüÇü ½º¸¶Æ® IV µå·¹½ÌÀÇ ÃâÇöÀº ¾÷°è¸¦ º¯È­½ÃŰ´Â ¶Ç ´Ù¸¥ ¹ßÀüÀÔ´Ï´Ù. ÀÌ Â÷¼¼´ë µå·¹½Ì Àç·á´Â ¿Âµµ, ¼öºÐ ¼öÁØ, Á¡Àû ºÎÀ§ÀÇ °¨¿° °¡´É¼ºÀ» ¸ð´ÏÅ͸µÇÏ´Â ¼¾¼­°¡ ³»ÀåµÇ¾î ÀÖ¾î ÀÇ·áÁø¿¡°Ô ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ Çõ½ÅÀº ȯÀÚÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ°ú °¨¿°ÀÇ Á¶±â ¹ß°ßÀ» °­È­ÇÏ¿© ÀçÅà ¹× º´¿ø¿¡¼­ÀÇ Á¤¸ÆÁÖ»ç Ä¡·áÀÇ ÇÕº´ÁõÀ» °¨¼Ò½ÃÄ×½À´Ï´Ù.

IV µå·¹½ÌÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ½ÃÀå µ¿ÇâÀº?

¸î °¡Áö Æ®·»µå°¡ IV µå·¹½Ì ½ÃÀåÀÇ ¼ºÀå°ú ÁøÈ­¸¦ Çü¼ºÇϰí ÀÖÀ¸¸ç, Àüü ÀÇ·á½Ã¼³ÀÇ Á¦Ç° Çõ½Å°ú äÅÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â °¨¿° ¿¹¹æ°ú º´¿ø ³» °¨¿°(HAI) °¨¼Ò¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC), ¼¼°èº¸°Ç±â±¸(WHO), ½ÄǰÀǾ౹(FDA) µî ±ÔÁ¦±â°üÀÌ °¨¿°°ü¸® ÇÁ·ÎÅäÄÝÀ» °­Á¶ÇÏ´Â °¡¿îµ¥, º´¿ø°ú ÀÇ·á±â°üÀº °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ Ç×±Õ ÄÚÆÃ°ú ³»½À¼ºÀ» °®Ãá ÷´Ü IV µå·¹½ÌÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â ÀçÅà ¼ö¾× ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¸¸¼ºÁúȯ, ¾Ï Ä¡·á, Àå±â Åõ¾à Áõ°¡·Î ÀÎÇØ ÀçÅÃÀÇ·á ¼­ºñ½º°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. º´¿ø ÀÌ¿ÜÀÇ Àå¼Ò¿¡¼­ Á¤¸Æ ³» Ä¡·á¸¦ ¹Þ´Â ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ºñÀÓ»ó ȯ°æ¿¡¼­ ³»±¸¼º°ú Æí¾ÈÇÔ, °¨¿° ¿¹¹æ, »ç¿ë ÆíÀǼºÀ» Á¦°øÇÏ´Â Àå½Ã°£ Âø¿ëÀÌ °¡´ÉÇÑ Á¤¸Æ ³» µå·¹½Ì¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Àå±â Ä«Å×ÅÍ Ä¡·á ¹× Áß½ÉÁ¤¸ÆÄ«Å×ÅÍ(CVC)ÀÇ »ç¿ë È®´ëµµ °í¼º´É IV µå·¹½Ì¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¸»ÃÊ»ðÀÔÇü Áß½ÉÁ¤¸ÆÄ«Å×ÅÍ(PICC ¶óÀÎ), ÅͳÎÇü Ä«Å×ÅÍ, À̽ÄÇü Æ÷Æ®¸¦ »ç¿ëÇϴ ȯÀÚ´Â Àå½Ã°£ Âø¿ëÇÒ ¼ö ÀÖÀ¸¸é¼­ Å»¶ôÀ̳ª ÀÚ±ØÀ» ¹æÁöÇÏ´Â ¾ÈÀüÇϰí Åë±â¼ºÀÌ ÁÁÀº IV µå·¹½ÌÀÌ ÇÊ¿äÇÕ´Ï´Ù. Á¾¾çÇÐ, ½ÅÀåÇÐ, ¿ÏÈ­ÀÇ·á ¼­ºñ½º°¡ È®´ëµÊ¿¡ µû¶ó Àå±â »ç¿ë¿¡ ƯȭµÈ IV µå·¹½ÌÀÌ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Áö¼Ó°¡´É¼º°ú ģȯ°æ µå·¹½Ì ¼ÒÀç°¡ ¼ºÀå Æ®·»µå·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀº ÀÇ·á Æó±â¹°°ú ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̱â À§ÇØ »ýºÐÇØ¼º ¹× ¹«ÇØÇÑ µå·¹½Ì Àç·á¸¦ °í·ÁÇϰí ÀÖ½À´Ï´Ù. °¢ Á¦Á¶¾÷üµéÀº ģȯ°æ ÇコÄɾî ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÀÀÇϱâ À§ÇØ ¶óÅØ½º ÇÁ¸®, ÀúÀڱؼº, ģȯ°æ IV µå·¹½ÌÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù.

¼ö¾× µå·¹½Ì ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

IV µå·¹½Ì ½ÃÀåÀº ÀÇ·áºñ ÁöÃâ Áõ°¡, ¸¸¼º ÁúȯÀÇ È®»ê, ÀÇ·á¿ë Á¢ÂøÁ¦ ±â¼úÀÇ ¹ßÀü µî ¸î °¡Áö ÁÖ¿ä ÃËÁø¿äÀο¡ ÀÇÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â Ä«Å×ÅÍ °ü·Ã Ç÷·ù °¨¿°(CRBSI)¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¾ö°ÝÇÑ °¨¿° ¹æÁö ´ëÃ¥ÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÔ´Ï´Ù. °¨¿° ¿¹¹æ ÁöħÀÌ °­È­µÊ¿¡ µû¶ó º´¿ø°ú ÀÇ·á½Ã¼³Àº À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ Ç×±Õ ÄÚÆÃ°ú Á¢Âø·ÂÀÌ °³¼±µÈ °í¼º´É IV µå·¹½Ì¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¶Ç ´Ù¸¥ ÁÖ¿ä ¿äÀÎÀº ³ëÀÎ Àα¸ Áõ°¡¿Í Àå±â Á¤¸Æ ³» Ä¡·á ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. Àα¸ °í·ÉÈ­¿¡ µû¶ó ¾Ï, ½ÅÀåÁúȯ, ½ÉÇ÷°üÁúȯ µî ÀæÀº Á¤¸ÆÁÖÀÔÀÌ ÇÊ¿äÇÑ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ Àå½Ã°£ Ä«Å×ÅÍ »ç¿ëÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â ³»±¸¼º°ú Æí¾ÈÇÔÀÌ ¶Ù¾î³­ IV µå·¹½ÌÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

»óó °ü¸® ¹× µå·¹½Ì Àç·áÀÇ ±â¼úÀû ÁøÈ­µµ ÷´Ü IV µå·¹½ÌÀÇ Ã¤Åÿ¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÇÏÀ̵å·ÎÄÝ·ÎÀ̵å, ½Ç¸®ÄÜ ÄÚÆ®, Åë±â¼º Çʸ§ µå·¹½ÌÀÇ µµÀÔÀ¸·Î ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ°í µå·¹½Ì ±³Ã¼ Ƚ¼ö¸¦ ÁÙ¿© ÇǺΠÀÚ±ØÀ» ÃÖ¼ÒÈ­ÇÏ¿´½À´Ï´Ù.

¶ÇÇÑ, °¨¿° ¿¹¹æ Á¶Ä¡¸¦ Áö¿øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ±ÔÁ¦ ±âÁØÀº °íǰÁú IV µå·¹½Ì¿¡ ´ëÇÑ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛ¿¡¼­´Â Á¤¸ÆÁÖ»ç ºÎÀ§ À¯Áö °ü¸® ¹× Ä«Å×ÅÍ °ü¸®¿¡ ´ëÇÑ º¸´Ù ¾ö°ÝÇÑ ÇÁ·ÎÅäÄÝÀ» µµÀÔÇϰí ÀÖÀ¸¸ç, º´¿øÀº ¹«±Õ¼º°ú ³»±¸¼ºÀ» Çâ»ó½ÃŰ´Â ÇÁ¸®¹Ì¾ö µå·¹½Ì ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ Àå·ÁÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ ÇコÄɾî¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀ¸·ÎÀÇ ÀüȯÀº ¼¾¼­°¡ ³»ÀåµÈ ½º¸¶Æ® IV µå·¹½Ì¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ µå·¹½Ì Àç·á´Â Ä«Å×ÅÍ ºÎÀ§¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí, °¨¿°À» Á¶±â¿¡ ¹ß°ßÇϰí, ÀÇ·áÁø¿¡°Ô ¿ø°ÝÀ¸·Î µ¥ÀÌÅ͸¦ Àü¼ÛÇÏ¿© ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̰í, ºÒÇÊ¿äÇÑ º´¿ø ¹æ¹®À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

¸¸¼º Áúȯ Áõ°¡, µå·¹½Ì Àç·áÀÇ ±â¼ú ¹ßÀü, °¨¿° ¿¹¹æ¿¡ ´ëÇÑ °ü½É Áõ°¡·Î IV µå·¹½Ì ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. º´¿ø, ÀçÅÃÄ¡·á ¼­ºñ½º Á¦°ø¾÷ü, ÀÇ·á±â±â Á¦Á¶¾÷üµéÀÌ Çõ½ÅÀ» °ÅµìÇÏ´Â °¡¿îµ¥, Á¢Âø·Â, Ç×±Õ¼º, ½º¸¶Æ® ¸ð´ÏÅ͸µ ±â´ÉÀ» °­È­ÇÑ Â÷¼¼´ë Á¤¸Æ ³» µå·¹½ÌÀÌ Á¤¸Æ ³» »óó °ü¸®¿Í ȯÀÚ ¾ÈÀüÀÇ ¹Ì·¡¸¦ Çü¼ºÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

À¯Çü(Åõ¸í, ¹ÝÅõ¸í);ÃÖÁ¾ »ç¿ë(º´¿ø, Ŭ¸®´Ð, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global IV Dressings Market to Reach US$2.2 Billion by 2030

The global market for IV Dressings estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Transparent, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Translucent segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$465.4 Million While China is Forecast to Grow at 8.1% CAGR

The IV Dressings market in the U.S. is estimated at US$465.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$458.7 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

IV Dressings Market - Key Trends & Drivers Summarized

Intravenous (IV) dressings are a critical component in medical settings, ensuring the secure placement of IV catheters, preventing infections, and protecting the insertion site from external contaminants. IV dressings come in various materials, including transparent film dressings, hydrocolloid dressings, antimicrobial dressings, and foam dressings, designed to provide secure adhesion, breathability, and moisture control. As hospital-acquired infections (HAIs) and catheter-related bloodstream infections (CRBSIs) remain significant concerns in healthcare, the demand for advanced IV dressing solutions with antimicrobial properties and enhanced adhesion is growing.

With healthcare systems emphasizing infection control, patient comfort, and dressing durability, the market for IV dressings is expanding rapidly. Innovations in antimicrobial technology, moisture management, and breathable materials are driving product advancements, while the increasing adoption of home-based IV therapy and long-term catheter use is further fueling market demand.

How Are Technological Advancements Improving IV Dressings?

Recent technological innovations have significantly enhanced IV dressing performance, durability, and infection prevention capabilities. One of the most critical advancements is the integration of antimicrobial agents into IV dressings. Silver-infused and chlorhexidine-coated dressings have demonstrated effectiveness in reducing microbial colonization around IV insertion sites, helping to prevent CRBSIs and other catheter-related infections. These antimicrobial dressings are particularly beneficial for immunocompromised patients, long-term IV therapy recipients, and critical care settings.

Another key innovation is the development of breathable, moisture-regulating dressings. Modern IV dressings now incorporate high-permeability film materials and hydrocolloid layers that allow for moisture evaporation while maintaining a protective barrier against bacteria and external contaminants. This technology helps in reducing skin maceration and promoting longer wear time, especially in high-moisture environments and active patients.

Additionally, advancements in adhesive technology have led to the creation of gentle, non-irritating adhesives that offer secure adhesion without causing skin damage upon removal. This is particularly important for elderly patients, neonatal care, and those with fragile skin. Some IV dressings now incorporate silicone-based adhesives, which provide firm attachment while minimizing the risk of skin stripping and discomfort.

The emergence of sensor-integrated smart IV dressings is another game-changing development in the industry. These next-generation dressings are equipped with embedded sensors that monitor temperature, moisture levels, and potential signs of infection at the IV site, providing real-time data to healthcare providers. This innovation is enhancing remote patient monitoring and early infection detection, reducing complications in home-based and hospital IV therapy.

What Market Trends Are Driving the Growth of IV Dressings?

Several trends are shaping the growth and evolution of the IV dressing market, influencing product innovation and adoption across healthcare facilities. One of the most significant trends is the rising focus on infection prevention and hospital-acquired infection (HAI) reduction. With regulatory bodies such as the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the Food and Drug Administration (FDA) emphasizing infection control protocols, hospitals and healthcare providers are adopting advanced IV dressings with antimicrobial coatings and moisture-resistant properties to minimize infection risks.

Another key trend is the increasing demand for home-based IV therapy. The rise in chronic diseases, cancer treatments, and long-term intravenous medication administration has led to a surge in home healthcare services. As more patients receive IV therapy outside hospital settings, there is a growing need for user-friendly, long-wear IV dressings that provide durability, comfort, and infection protection in non-clinical environments.

The expansion of long-term catheterization and central venous catheter (CVC) use is also contributing to the demand for high-performance IV dressings. Patients with peripherally inserted central catheters (PICC lines), tunneled catheters, and implanted ports require secure and breathable IV dressings that prevent dislodgement and irritation while allowing extended wear. As oncology, nephrology, and palliative care services expand, specialized IV dressings designed for long-term use are gaining popularity.

Additionally, sustainability and eco-friendly dressing materials are emerging as a growing trend. Healthcare providers are increasingly considering biodegradable and non-toxic dressing options to reduce medical waste and environmental impact. Manufacturers are developing latex-free, hypoallergenic, and eco-conscious IV dressings to align with green healthcare initiatives.

What Is Driving the Growth of the IV Dressing Market?

The IV dressing market is expanding due to several key drivers, including rising healthcare expenditures, increasing chronic disease prevalence, and advancements in medical adhesive technology. One of the primary growth drivers is the growing awareness of catheter-related bloodstream infections (CRBSIs) and the need for stringent infection control measures. As infection prevention guidelines become more rigorous, hospitals and healthcare facilities are investing in high-performance IV dressings with antimicrobial coatings and improved adhesion to minimize risks.

Another major factor driving market growth is the expanding elderly population and increasing demand for long-term IV therapy. With an aging population, there is a rising prevalence of conditions requiring frequent IV access, such as cancer, kidney disease, and cardiovascular disorders. This has led to greater adoption of durable and comfortable IV dressings that facilitate extended catheter use.

The technological evolution of wound care and dressing materials is also fueling the adoption of advanced IV dressings. The introduction of hydrocolloid-based, silicone-coated, and breathable film dressings has improved patient comfort, reduced dressing changes, and minimized skin irritation, making these products more favorable in both hospital and home care settings.

Additionally, government initiatives and regulatory standards supporting infection prevention measures are influencing the demand for high-quality IV dressings. Healthcare systems worldwide are implementing stricter protocols for IV site maintenance and catheter care, prompting hospitals to invest in premium dressing solutions that enhance sterility and durability.

The shift toward digital healthcare and remote patient monitoring is further driving demand for smart IV dressings with embedded sensors. These innovative dressings enable continuous monitoring of catheter sites, early detection of infection, and remote data transmission to healthcare providers, enhancing patient safety and reducing unnecessary hospital visits.

With the increasing prevalence of chronic illnesses, technological advancements in dressing materials, and heightened focus on infection prevention, the IV dressing market is expected to experience sustained growth. As hospitals, home healthcare providers, and medical device manufacturers continue to innovate, next-generation IV dressings with enhanced adhesion, antimicrobial properties, and smart monitoring capabilities will shape the future of intravenous site care and patient safety.

SCOPE OF STUDY:

The report analyzes the IV Dressings market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Transparent, Translucent); End-Use (Hospitals, Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â